Madhavan Balachandran Sells Shares of Stevanato Group
Madhavan Balachandran sold 1,493 shares of Stevanato Group on June 15.
Key Points
- Madhavan Balachandran sold 1,493 shares of Stevanato Group valued at $25,515.37 on June 15, 2026.
- Shares of NYSE:STVN traded near $18.39 on Friday with a market cap of $5.02 billion and a P/E ratio of 31.71.
- Analysts have set a mean price target of $24.45 for Stevanato Group, with TD Cowen initiating coverage at a $25 target.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Madhavan Balachandran sold 1,493 shares of Stevanato Group S.p.A. (NYSE: STVN) on June 15, 2026. The shares were sold at an average price of $17.09, amounting to a total value of about $25,515. This transaction was not part of a pre-arranged trading plan.
Insider Buying and Selling at Stevanato Group S.p.A.
On June 15, several insiders, including Madhavan Balachandran, sold 1,493 shares each at $17.09. Meanwhile, on June 12, William Federici acquired 4,975 shares, and Marco Dal Lago, the Chief Financial Officer, bought 2,356 shares, both at no cost.
Other Institutional Activity in Stevanato Group
Among institutional investors, Conestoga Capital Advisors, LLC increased its holdings by 602,050 shares, ending with 8,491,751 shares worth about $116.76 million. Neuberger Berman Group LLC, however, trimmed its position by 312,219 shares, leaving it with 4,475,492 shares valued at approximately $61.54 million. T. Rowe Price Investment Management, Inc. reduced its stake by 698,724 shares, holding 3,224,908 shares worth around $44.34 million. Conversely, BAMCO Inc /NY/ grew its holdings by 498,714 shares to a total of 2,500,438 shares, valued at roughly $34.38 million.
Stevanato Group S.p.A. Stock Down 12.6%
Shares of Stevanato Group traded near $18.39 on Friday. The company has a market capitalization of approximately $5.02 billion and a P/E ratio of 31.71. Its forward P/E stands at 21.95, with a beta of 0.776. Over the past 52 weeks, the stock has ranged from a low of $12.89 to a high of $28.00. The 50-day moving average is $17.39, while the 200-day moving average is $19.57. Stevanato Group maintains a current ratio of 1.63 and a quick ratio of 1.11, with a debt-to-equity ratio of 29.43.
$STVN stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Stevanato Group reported revenue of $1.20 billion, marking a 6.6% growth. The company achieved a net margin of 11.75% with a return on equity of 9.59%. Earnings per share stood at $0.58. The next earnings report is expected on May 7, 2026.
Dividend
Stevanato Group pays an annual dividend rate of $0.06, which translates to a yield of 0.34%. The dividend payout ratio is 10.59%.
Analysts Set New Price Targets
On June 16, 2026, TD Cowen initiated coverage of Stevanato Group with a "buy" rating and a $25 price target. Earlier, on June 2, Wolfe Research assumed coverage with a "buy" rating and a $21 target. Analysts have given the stock a consensus "buy" recommendation, with a mean target price of $24.45 across 10 opinions.
About Stevanato Group
Stevanato Group S.p.A. designs and manufactures products and solutions for the biopharma and healthcare industries globally. Headquartered in Piombino Dese, Italy, the company operates in the Biopharmaceutical and Diagnostic Solutions and Engineering segments. It offers drug containment solutions, diagnostic laboratory consumables, and drug delivery systems. The company also provides contract development and manufacturing services. Founded in 1949, it employs around 6,010 people.
Bottom Line
Madhavan Balachandran's recent sale of Stevanato Group shares adds to the insider activity in the company. Investors often track such movements for potential insights. Keep in mind that these insider transactions are reported after they occur and may not reflect the insider's current holdings.
Get Stevanato Group S.p.A. alerts
New 13F filings, insider trades, and analyst moves on $STVN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.